Jason Cohen

About the Author Jason Cohen

Jason is a Smarter Analyst editor and writer, who specializes in biotech and cannabis-based pharmaceutical companies.

Cannabis Strategies Acquisition (CBAQF) Stock at $26? Northland Thinks It’s Possible

There’s little doubt that the burgeoning pot industry offers plenty of opportunity for investors. According to a report by BDS Analytics, global consumer cannabis spending is expected to skyrocket by 38% in 2019 to $16.9 billion, up from an estimated $12.2 billion in 2018, $9.5 billion in 2017, and $6.9 billion in 2016. Furthermore, compound annual sales growth between 2017 and 2022 is expected to clock in at 26.7%, with the report calling for $31.3 billion in global marijuana sales in 2022.

The question remains: Which marijuana stocks to buy?

Northland analyst Paul Penney believes Cannabis Strategies Acquisition Corp. (CBAQF) is in prime position to become one of the nation’s premier recreational & medical legalized cannabis providers. As a result, Penney initiates coverage on the stock with an Outperform rating and price target of $26, which implies a potential upside of 90% from current levels. (To watch Penney’s track record, click here)

Cannabis Strategies Acquisition Corp. (CSAC) is a SPAC (Special Purpose Acquisition Corporation) that initially listed in Canada in December 2017 with the overall goal to become “one of the leading vertically integrated cannabis owners/operators across the United States.” On October 17, 2018, CSAC announced the acquisition of 5 cannabis related companies to create what the Company refers to as the “Anchor Portfolio.”

Penney believes “CSAC has not only stealthily accumulated a high quality set of retail brands / stores in highly favorable (large populations / disposal incomes with limiting number of licenses) legalized cannabis markets (NV & MA), but has an extensive pipeline of strategic / accretive acquisitions on the come (MI, CA, FL, etc.) that will further augment / broaden their geographic reach.” The analyst continued, “With an extremely smart / capable management team, we believe CSA will have both a highly efficient / scalable operating process and a strategic / highly profitable growth focus that will cumulatively equate to industry leading profitability / margins and emergence as one of the leading / reputable MSOs in legalized cannabis over a longer term basis. Further and post the SPAC closing (likely early April), we believe institutional awareness will be greatly enhanced under a more unified / cannabis centric name.”

Check out the articles in this category focused on cannabis stocks. By gaining a strong foundation in both the fundamentals and technical details usually involved in cannabis stocks, you’ll be able to invest with greater confidence.


Stay Ahead of Everyone Else

Get The Latest Stock News Alerts